Exact Mass: 478.3423076
Exact Mass Matches: 478.3423076
Found 324 metabolites which its exact mass value is equals to given mass value 478.3423076,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Carpaine
Pseudocarpaine is found in fruits. Minor alkaloid from leaves of Carica papaya (papaya Alkaloid from leaves of Carica papaya (papaya)
Polyporusterone A
Polyporusterone A is found in mushrooms. Polyporusterone A is a constituent of Polyporus umbellatus (zhu ling). Constituent of Polyporus umbellatus (zhu ling). Polyporusterone A is found in mushrooms. Polyporusterone A is a triterpene carboxylic acid isolated from Polyporus umbellatus Fries. Polyporusterone A has inhibitory effect on free radical-induced lysis of red blood cells (hemolysis)[1]. Polyporusterone A is a triterpene carboxylic acid isolated from Polyporus umbellatus Fries. Polyporusterone A has inhibitory effect on free radical-induced lysis of red blood cells (hemolysis)[1].
Dolicholide
Dolicholide is found in common bean. Dolicholide is a constituent of Dolichos lablab (hyacinth bean).
25-Acetylvulgaroside
25-Acetylvulgaroside is found in fruits. 25-Acetylvulgaroside is a constituent of Cydonia vulgaris (quince). Constituent of Cydonia vulgaris (quince). 25-Acetylvulgaroside is found in fruits.
Erinacine D
Erinacine D is found in mushrooms. Erinacine D is a metabolite of Hericium erinaceum (lions mane Metabolite of Hericium erinaceum (lions mane). Erinacine D is found in mushrooms.
Deterrol stearate
Deterrol stearate is found in mushrooms. Deterrol stearate is isolated from the mushrooms Lactarius specie Isolated from the mushrooms Lactarius subspecies Deterrol stearate is found in mushrooms.
(1‐{[1‐carboxylato‐3‐(trimethylammonio)propan‐2‐ yl]oxy}‐1‐oxoicosa‐5,7,11,14‐tetraen‐9‐yl)peroxy
C27H44NO6 (478.31684640000003)
(1‐{[1‐Carboxylato‐3‐(trimethylammonio)propan‐2‐ yl]oxy}‐1‐oxoicosa‐5,7,11,14‐tetraen‐9‐yl)peroxy is an acylcarnitine. More specifically, it is an (1‐carboxynonadeca‐4,6,10,13‐tetraen‐8‐yl)peroxy ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279 ). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (1‐{[1‐Carboxylato‐3‐(trimethylammonio)propan‐2‐ yl]oxy}‐1‐oxoicosa‐5,7,11,14‐tetraen‐9‐yl)peroxy is therefore classified as a long chain AC. As a long-chain acylcarnitine (1‐{[1‐carboxylato‐3‐(trimethylammonio)propan‐2‐ yl]oxy}‐1‐oxoicosa‐5,7,11,14‐tetraen‐9‐yl)peroxy is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748 ). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774 ). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903 ). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394 ). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
(20‐{[1‐Carboxylato‐3‐(trimethylammonio)propan‐2‐ yl]oxy}‐20‐oxoicosa‐6,8,12,15‐tetraen‐10‐yl)peroxy
C27H44NO6 (478.31684640000003)
(20‐{[1‐Carboxylato‐3‐(trimethylammonio)propan‐2‐ yl]oxy}‐20‐oxoicosa‐6,8,12,15‐tetraen‐10‐yl)peroxy is an acylcarnitine. More specifically, it is an [(4Z,7Z,11E,13Z)-1-carboxynonadeca-4,7,11,13-tetraen-10-yl]peroxy ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (20‐{[1‐Carboxylato‐3‐(trimethylammonio)propan‐2‐ yl]oxy}‐20‐oxoicosa‐6,8,12,15‐tetraen‐10‐yl)peroxy is therefore classified as a long chain AC. As a long-chain acylcarnitine (20‐{[1‐carboxylato‐3‐(trimethylammonio)propan‐2‐ yl]oxy}‐20‐oxoicosa‐6,8,12,15‐tetraen‐10‐yl)peroxy is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
Homocastasterone
(24S)-24-Ethylbrassinone
(24s)-24-ethylbrassinone is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). (24s)-24-ethylbrassinone can be found in tea, which makes (24s)-24-ethylbrassinone a potential biomarker for the consumption of this food product.
24-Ethylbrassinone
24-ethylbrassinone is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 24-ethylbrassinone can be found in tea, which makes 24-ethylbrassinone a potential biomarker for the consumption of this food product.
6-Keto-28-homobrassinolide
6-keto-28-homobrassinolide belongs to stigmastanes and derivatives class of compounds. Those are sterol lipids with a structure based on the stigmastane skeleton, which consists of a cholestane moiety bearing an ethyl group at the carbon atom C24. 6-keto-28-homobrassinolide is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 6-keto-28-homobrassinolide can be found in tea, which makes 6-keto-28-homobrassinolide a potential biomarker for the consumption of this food product.
(2beta,3beta,14alpha,20R,22R)-2,3,14,20,22,25-hexahydroxycholesta-4,7-dien-6-one
1beta,2beta,3beta,4beta,5beta-pentahydroxyspirost-25(27)-ene|Delta25(27)-pentrogenin|Delta25(27)pentologenin|Delta25(27)pentrogenin|spirost-25(27)-ene-1beta,2beta,3beta,4beta,5beta-pentaol
(13R)-labda-7,14-diene 13-O-alpha-L-(4-O-acetyl)-6-deoxyidopyranoside|labda-7,14-dien-13(R)-ol-4-O-acetyl-alpha-L-6-deoxyidopyranoside
astern-13(S)-1(10),14-diene-13-O-alpha-L-2-acetylrhamnopyranoside
14alpha,15alpha-epoxy-14,15-dihydrostachysterone B
abiesanolide B|methyl 3,4-seco-8(14->13R)abeo-17,13-friedo-9beta-lanosta-4(28),7,14(30),22Z,24-pentaen-26,23-olide-3-oate
25xi-cholestane-3beta,5alpha,6beta,26-tetrol-26-acetate|cholestane-3beta,5alpha,6beta-26-tetrol 27-acetate
labda-7,14-dien-13(R)-ol-2-O-acetyl-alpha-L-rhamnopyranoside
(20S*)-24xi-ethyl-3beta,6alpha,11,20-tetrahydroxy-9,11-seco-5alpha-cholest-7-en-9-one
24-methylcholestane-3beta,5alpha,6beta,25-tetrol 25-monoacetate
(E)-(24R,25R)-23,24-dimethyl-5alpha-cholest-22-ene-3beta,6alpha,8,15beta,26-pentol|certonardosterol I
amphimedoside C|N-methoxy-N-(14-pyridin-3-yltetradec-11-yn-1-yl)-beta-D-glucopyranosylamine
7beta-acetoxy-6alpha-(2-methylbutyryloxy)-13,14-dihydrokolavenic acid methyl ester|7beta-acetoxy-6alpha-<2-methylbutyryloxy>-13,14-dihydrokolavenic acid methyl ester
(25S)-3beta,4beta,6alpha,8,26-pentahydroxy-24-methyl-5alpha-cholest-24(241)-en-15-one|certonardosterol Q1
labda-7,14-dien-13(R)-ol-3-O-acetyl-alpha-L-rhamnopyranoside
9,10-epoxy-6alpha-O-tigloyl-7alphaH-8beta-O-(3-acetoxy-2-methylbutyryl)germacra-3(4)E-ene|trijugin I
ST 28:2;O6
Polyporusterone A is a steroid. Polyporusterone A is a natural product found in Polyporus umbellatus with data available. Polyporusterone A is a triterpene carboxylic acid isolated from Polyporus umbellatus Fries. Polyporusterone A has inhibitory effect on free radical-induced lysis of red blood cells (hemolysis)[1]. Polyporusterone A is a triterpene carboxylic acid isolated from Polyporus umbellatus Fries. Polyporusterone A has inhibitory effect on free radical-induced lysis of red blood cells (hemolysis)[1].
(2S,3R,10R,13R,14S)-17-[(2R,3R,5S)-2,3-dihydroxy-5,6-dimethylheptan-2-yl]-2,3,14-trihydroxy-10,13-dimethyl-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one
(2S,3R,10R,13R,14S)-17-[(2R,3R,5S)-2,3-dihydroxy-5,6-dimethylheptan-2-yl]-2,3,14-trihydroxy-10,13-dimethyl-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one [IIN-based on: CCMSLIB00000848325]
(2S,3R,10R,13R,14S)-17-[(2R,3R,5S)-2,3-dihydroxy-5,6-dimethylheptan-2-yl]-2,3,14-trihydroxy-10,13-dimethyl-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one [IIN-based: Match]
(7E)-(1R,2S,3R)-2-(3-hydroxypropoxy)-19-nor-9,10-seco-5,7-cholestadiene-1,3,25-triol
(7E)-(1R,2R,3R)-2-(3-hydroxypropoxy)-19-nor-9,10-seco-5,7-cholestadiene-1,3,25-triol
24-methylene-cholesterol sulfate
C28H46O4S (478.31166360000003)
Erinacine D
Dolicholide
Polyporusterone A
Polyporusterone A is a triterpene carboxylic acid isolated from Polyporus umbellatus Fries. Polyporusterone A has inhibitory effect on free radical-induced lysis of red blood cells (hemolysis)[1]. Polyporusterone A is a triterpene carboxylic acid isolated from Polyporus umbellatus Fries. Polyporusterone A has inhibitory effect on free radical-induced lysis of red blood cells (hemolysis)[1].
25-Acetylvulgaroside
1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)-19-norvitamin D3
N,N-dimethyl-4-[2-(2-octoxyphenyl)-6-phenylpyridin-4-yl]aniline
(9 9-BIS(2-ETHYLHEXYL)-9H-FLUORENE-2 7-&
C29H44B2O4 (478.34255240000005)
(5-Amino-2-butyl-3-benzofuranyl)[4-[3-(dibutylamino)propoxy]phenyl]methanone
C30H42N2O3 (478.31952620000004)
Bis(2,6-di-Tert-Butyl-4-Methylphenoxy)Methylaluminum
C31H47AlO2 (478.33912719999995)
ETHYLTRI-N-OCTYLPHOSPHONIUM BROMIDE
C26H56BrP (478.33027660000005)
12-(Acetyloxy)-3,6-dihydroxy-7-oxocholan-24-oic acid methyl ester
sodium,(1S,2R,4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylate
N-(1-oxododecyl)-L-glutamic acid, compound with 2,2,2-nitrilotrisethanol (1:1)
C23H46N2O8 (478.32539959999997)
1,1,3,3-Tetraethoxy-1,3-dioctyldisiloxane
C24H54O5Si2 (478.35095939999997)
9,9-Dioctylfluorene-2,7-diboronic acid
C29H44B2O4 (478.34255240000005)
1,3-bis-(2,6-di-Isopropylphenyl)-4,5-dihydroimidazolium tetrafluoroborate
C27H39BF4N2 (478.31422519999995)
N-[2-[2-[(dipropylamino)methyl]piperidin-1-yl]ethyl]-6-oxo-5H-pyrido[2,3-b][1,4]benzodiazepine-11-carboxamide
C27H38N6O2 (478.30560879999996)
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics
1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)-19-norvitamin D3/1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)-19-norcholecalciferol
N-oleoyl-sn-glycero-3-phosphoethanolamine(1-)
C23H45NO7P- (478.29334900000003)
(E)-16-(3-(4-hydroxy-3,5-dimethoxyphenyl)acryloyloxy)hexadecanoic acid
(2R,6Z,9Z,12Z,15Z)-3-oxo-2-[(2Z,5Z,8Z,11Z)-tetradeca-2,5,8,11-tetraenyl]octadeca-6,9,12,15-tetraenoic acid
[3-carboxy-2-[(13E,16E,19E)-docosa-13,16,19-trienoyl]oxypropyl]-trimethylazanium
C29H52NO4+ (478.38961320000004)
(1-{[1-Carboxylato-3-(trimethylammonio)propan-2-yl]oxy}-1-oxoicosa-5,7,11,14-tetraen-9-yl)peroxy
C27H44NO6 (478.31684640000003)
(20-{[1-Carboxylato-3-(trimethylammonio)propan-2-yl]oxy}-20-oxoicosa-6,8,12,15-tetraen-10-yl)peroxy
C27H44NO6 (478.31684640000003)
[3-carboxy-2-[(7E,10E,13E)-docosa-7,10,13-trienoyl]oxypropyl]-trimethylazanium
C29H52NO4+ (478.38961320000004)
[3-carboxy-2-[(E)-7-[2-[(E)-3-hydroxyoct-1-enyl]-5-oxocyclopent-2-en-1-yl]hept-5-enoyl]oxypropyl]-trimethylazanium
C27H44NO6+ (478.31684640000003)
[3-carboxy-2-[(E)-7-[(2Z)-5-hydroxy-2-[(E)-oct-2-enylidene]-3-oxocyclopentyl]hept-5-enoyl]oxypropyl]-trimethylazanium
C27H44NO6+ (478.31684640000003)
[3-carboxy-2-[(E)-7-[2-[(E)-3-hydroxyoct-1-enyl]-5-oxocyclopenten-1-yl]hept-5-enoyl]oxypropyl]-trimethylazanium
C27H44NO6+ (478.31684640000003)
(5Z,8Z,11Z,14Z)-N-[2-(5-hydroxy-2-oxo-2,3-dihydro-1H-indol-3-yl)ethyl]icosa-5,8,11,14-tetraenamide
C30H42N2O3 (478.31952620000004)
(2beta,3beta,9epsilon,17epsilon,22R)-2,3,14,20,22-Pentahydroxyergost-7-en-6-one
(2R,3S)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(3-methylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(5Z)-7-{1-[(5S)-5-amino-5-carboxypentyl]-4-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-2-methyl-5-oxo-2,5-dihydro-1H-pyrrol-3-yl}hept-5-enoic acid
2-[4-(2-Aminoethyl)-2-hydroxyphenoxy]ethyl-trimethylammonium 2-[5-(2-aminoethyl)-2-hydroxyphenoxy]ethyl-trimethylammonium
(2-hydroxy-3-phosphonooxypropyl) (Z)-henicos-11-enoate
[17-[(E)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate
C28H46O4S (478.31166360000003)
[(E)-3-hydroxy-2-(nonanoylamino)non-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-2-(hexanoylamino)-3-hydroxydodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-2-(heptanoylamino)-3-hydroxyundec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-3-hydroxy-2-(octanoylamino)dec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-2-(butanoylamino)-3-hydroxytetradec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-3-hydroxy-2-(propanoylamino)pentadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-2-acetamido-3-hydroxyhexadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-3-hydroxy-2-(pentanoylamino)tridec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-2-(decanoylamino)-3-hydroxyoct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
(1-decanoyloxy-3-hydroxypropan-2-yl) (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
(1-hydroxy-3-octanoyloxypropan-2-yl) (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
(1-hexanoyloxy-3-hydroxypropan-2-yl) (11Z,14Z,17Z)-icosa-11,14,17-trienoate
(1-butanoyloxy-3-hydroxypropan-2-yl) (10Z,13Z,16Z)-docosa-10,13,16-trienoate
(2-decanoyloxy-3-hydroxypropyl) (9E,11E,13E)-hexadeca-9,11,13-trienoate
[2-[(E)-dec-4-enoyl]oxy-3-hydroxypropyl] (4E,7E)-hexadeca-4,7-dienoate
2-[[3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C24H49NO6P+ (478.32973240000007)
Carpaine
An alkaloid that forms a major component of the papaya leaves and has been shown to exhibit cardiovascular effects.
pregnenolone 3-beta-D-glucoside
A sterol 3-beta-D-glucoside in which the sterol is 3beta-hydroxypregn-5-en-20-one.
N-arachidonoyl-2-oxoserotonin
C30H42N2O3 (478.31952620000004)
A fatty amide obtained by formal condensation of the carboxy group of arachidonic acid with the amino group of 2-oxoserotonin.
DG(26:3)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
TG(25:3)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
LSM(19:1)
C24H51N2O5P (478.35354060000003)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
LSM(20:0)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
(2e,4e,6e,8e)-10-[(3z,3as,9ar,9bs)-3a,6,6,9a-tetramethyl-2,7-dioxo-hexahydro-1h-cyclopenta[a]naphthalen-3-ylidene]-2,4,6-trimethylundeca-2,4,6,8-tetraenoic acid
(1's,2r,2's,4's,7's,8'r,9's,12's,13's,14's,15's,16's,17's,18'r)-7',9',13'-trimethyl-5-methylidene-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-14',15',16',17',18'-pentol
(1s,2s,3r,4s,7s,8r,11s,12r,14r,17s)-4,14-dihydroxy-4,8,11-trimethyl-15-methylidene-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-12-yl octanoate
1-(5,6-dimethylhept-3-en-2-yl)-3a,3b,5,5a,7-pentahydroxy-9a,11a-dimethyl-decahydro-1h-cyclopenta[a]phenanthren-4-one
9,30-dioxa-11,25-diazapentacyclo[20.6.2.2⁸,¹¹.0¹⁰,¹⁵.0²⁵,²⁹]dotriacontane-1,15-diol
7',9',13'-trimethyl-5-methylidene-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-14',15',16',17',18'-pentol
[5,5a,7-trihydroxy-9a-methyl-1-(6-methylheptan-2-yl)-tetradecahydrocyclopenta[a]phenanthren-11a-yl]methyl acetate
3,4,5-trihydroxy-6-{2-hydroxy-3-[(13-methyltetradecyl)oxy]propoxy}oxane-2-carboxylic acid
8a-[(acetyloxy)methyl]-3,6-dihydroxy-8-(3-hydroxy-3-methylpent-4-en-1-yl)-4,4-dimethyl-7-methylidene-hexahydro-1h-naphthalen-2-yl 2-methylbut-2-enoate
8,8-dimethyl-2,9-dioxatetracyclo[25.3.1.0³,¹².0⁵,¹⁰]hentriaconta-1(30),3,5(10),6,11,27(31),28-heptaene-4,29-diol
[(1r,3as,3bs,5r,5ar,7s,9ar,9bs,11as)-5,5a,7-trihydroxy-9a-methyl-1-[(2r)-6-methylheptan-2-yl]-tetradecahydrocyclopenta[a]phenanthren-11a-yl]methyl acetate
(3ar,5ar,6s,9s,10ar)-9-ethoxy-1-isopropyl-3a,5a-dimethyl-6-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-2h,3h,4h,5h,6h,9h,10h,10ah-cyclohepta[e]indene-8-carbaldehyde
(1r,11r,13s,14s,24r,26s)-13,26-dimethyl-2,15-dioxa-12,25-diazatricyclo[22.2.2.2¹¹,¹⁴]triacontane-3,16-dione
(4e,6z,14r,18r,19z,21e,29s,30r)-1,16-diazatetracyclo[27.3.1.1¹²,¹⁶.0¹⁴,³⁰]tetratriaconta-4,6,12,19,21-pentaen-18-ol
(1s,2r,4r,8e,10z,12e,15e,17r,18s)-5,20-diazapentacyclo[18.12.1.1¹,⁵.0²,¹⁸.0⁴,¹⁶]tetratriaconta-8,10,12,15-tetraen-17-ol
3a,7-dihydroxy-9a,11a-dimethyl-1-(2,3,6-trihydroxy-6-methylheptan-2-yl)-1h,2h,3h,5ah,6h,7h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,8-dione
22-oxo-20-hydroxyecdysone
{"Ingredient_id": "HBIN003750","Ingredient_name": "22-oxo-20-hydroxyecdysone","Alias": "NA","Ingredient_formula": "C27H42O7","Ingredient_Smile": "CC12CCC3C(=CC(=O)C4C3(CC(C(C4)O)O)C)C1(CCC2C(C)(C(=O)CCC(C)(C)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "16339","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
22-oxo-ajugasterone c
{"Ingredient_id": "HBIN003751","Ingredient_name": "22-oxo-ajugasterone c","Alias": "NA","Ingredient_formula": "C27H42O7","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "16280","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}